Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2019 Feb 15;28(5):846–856. doi: 10.1158/1055-9965.EPI-18-0801

Figure 1.

Figure 1

contains childhood acute lymphoblastic leukemia (ALL) incidence rates from the Surveillance, Epidemiology, and End Results program (SEER) 18 registries (2000–2014) for all ages (0–19 years) and stratified by age group (<1 year, 1–9 years, 10–19 years) (a). The cytogenomic subtypes of childhood B-ALL immunophenotype overall and by age at diagnosis categories (<1 year, 1–9 years, 10–19 years) are presented (b). The cytogenomic subtypes of childhood T-ALL immunophenotype overall are presented (c). Categories assumed to be mutually exclusive.